Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vaxart Inc (VXRT)

Vaxart Inc (VXRT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,100,164
  • Shares Outstanding, K 109,469
  • Annual Sales, $ 9,860 K
  • Annual Income, $ -18,650 K
  • 60-Month Beta 0.44
  • Price/Sales 96.26
  • Price/Cash Flow N/A
  • Price/Book 5.79
Trade VXRT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.08
  • Number of Estimates 3
  • High Estimate -0.02
  • Low Estimate -0.13
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +38.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.28 +79.83%
on 01/04/21
10.81 -12.16%
on 01/26/21
+2.71 (+40.04%)
since 12/24/20
3-Month
3.50 +171.29%
on 11/09/20
10.81 -12.16%
on 01/26/21
+4.24 (+80.86%)
since 10/26/20
52-Week
0.56 +1,595.54%
on 01/27/20
17.49 -45.71%
on 07/14/20
+9.00 (+1,822.06%)
since 01/24/20

Most Recent Stories

More News
Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication

New pre-clinical histology data show that Vaxart's oral vaccine protected against lung inflammation in hamster models

VXRT : 9.52 (-5.27%)
Do Options Traders Know Something About Vaxart (VXRT) Stock We Don't?

Investors need to pay close attention to Vaxart (VXRT) stock based on the movements in the options market lately.

VXRT : 9.52 (-5.27%)
Emergent (EBS) Posts Preliminary '20 Results, Gives 2021 View

Emergent (EBS) tightens revenue view for 2020 and expects a consistent rise in sales of contract development and manufacturing services provided to other companies.

JNJ : 169.99 (+2.42%)
NVAX : 127.66 (-2.89%)
EBS : 108.98 (+2.45%)
VXRT : 9.52 (-5.27%)
3 Biotech Stocks on the Robinhood 100 to AVOID

The Robinhood app is popular among millennial investors. And as the Covid-19 pandemic focused attention on the biotech industry last year, many young investors rushed to bet on the sector. Though market...

CPRX : 3.69 (-0.54%)
VXRT : 9.52 (-5.27%)
SRNE : 10.45 (+12.61%)
Did You Acquire (VXRT) Before June 25, 2020? Johnson Fistel Investigates Vaxart; Should Management be Held Accountable for Investors Losses?

, /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, investigates potential claims against Vaxart, Inc. (NASDAQ: VXRT) for violations of federal securities laws.

VXRT : 9.52 (-5.27%)
4 Small COVID-19 Vaccine Makers to Look Out for in 2021

Here we discuss four small biotech companies, NVAX, CVAC, VXRT and ARCT, that are making COVID-19 vaccine candidates, which may be approved in 2021, if successfully developed, and bring profits.

PFE : 37.38 (+0.27%)
NVAX : 127.66 (-2.89%)
ARCT : 65.00 (-6.39%)
VXRT : 9.52 (-5.27%)
BNTX : 106.20 (-3.99%)
CVAC : 99.13 (-5.14%)
Thinking about trading options or stock in Baidu, Vaxart, Nio, Norwegian Cruise Line, or Blink Charging?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BIDU, VXRT, NIO, NCLH, and BLNK.

BIDU : 248.49 (-2.50%)
BLNK : 60.86 (+32.77%)
VXRT : 9.52 (-5.27%)
NCLH : 23.66 (-1.29%)
NIO : 60.08 (+0.15%)
Comprehensive Diagnostics Remains a Priority As More Surges are Expected

, /PRNewswire/ -- When Pfizer and BioNTech SE announced earlier in November a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate,...

VXRT : 9.52 (-5.27%)
TOMDF : 0.0580 (-3.33%)
BNTX : 106.20 (-3.99%)
CEMI : 6.81 (+3.97%)
DVAX : 6.15 (-6.11%)
Do Options Traders Know Something About Vaxart (VXRT) Stock We Don't?

Investors need to pay close attention to Vaxart (VXRT) stock based on the movements in the options market lately.

VXRT : 9.52 (-5.27%)
The Zacks Analyst Blog Highlights: INO, NVAX, TBIO and VXRT

The Zacks Analyst Blog Highlights: INO, NVAX, TBIO and VXRT

NVAX : 127.66 (-2.89%)
TBIO : 23.16 (-5.97%)
INO : 10.57 (+8.74%)
VXRT : 9.52 (-5.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick...

See More

Key Turning Points

3rd Resistance Point 14.79
2nd Resistance Point 12.74
1st Resistance Point 11.40
Last Price 9.46
1st Support Level 8.01
2nd Support Level 5.96
3rd Support Level 4.62

See More

52-Week High 17.49
Fibonacci 61.8% 11.02
Last Price 9.46
Fibonacci 50% 9.02
Fibonacci 38.2% 7.03
52-Week Low 0.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar